ST7 binds YBX1 to suppress MMP14 expression and inhibit metastasis in non-small cell lung cancer

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Non-small cell lung cancer (NSCLC) is a leading cause of cancer mortality worldwide.
• Epithelial-mesenchymal transition (EMT) is a key driver of NSCLC metastasis, but its regulatory mechanisms are not fully understood.

Purpose of the Study:

• To investigate the role of Suppression of tumorigenicity 7 (ST7) in regulating NSCLC metastasis.
• To elucidate the molecular mechanisms by which ST7 influences EMT and cancer cell invasion.

Main Methods:

• Analysis of The Cancer Genome Atlas - Lung Adenocarcinoma (TCGA-LUAD) dataset.
• In vitro studies using NSCLC cell lines (A549, H1299) with ST7 silencing.
• In vivo experiments using a tail-vein lung metastasis model in BALB/c nude mice.
• Investigation of the interaction between ST7, Y-box binding protein 1 (YBX1), and Matrix metalloproteinase 14 (MMP14).

Main Results:

• ST7 was identified as a potential inhibitor of EMT and metastasis in NSCLC.
• ST7 directly binds to YBX1, preventing its nuclear translocation and subsequently suppressing MMP14 expression.
• Silencing of ST7 promoted EMT and enhanced metastatic progression in both in vitro and in vivo NSCLC models.
• A novel ST7/YBX1/MMP14 signaling axis was identified.

Conclusions:

• The ST7/YBX1/MMP14 axis represents a novel regulatory pathway in NSCLC metastasis.
• Targeting this signaling axis may offer a potential therapeutic strategy for inhibiting NSCLC progression and metastasis.